Chapters

Transcript

HPV-related oropharynx cancer discoveries

Name: HPV-related oropharynx cancer discoveries
Uploaded: 2019-10-31T00:00:00+00:00
Description: Experts from Mayo Clinic's Head and Neck Cancer Center discuss the latest discoveries in HPV-related oropharynx cancers and the importance of spotting symptoms to ensure your patient receives the tests needed to diagnose and treat the cancer.

Experts from Mayo Clinic's Head and Neck Cancer Center discuss the latest discoveries in HPV-related oropharynx cancers and the importance of spotting symptoms to ensure your patient receives the tests needed to diagnose and treat the cancer.

Published

October 31, 2019

Created by

Related Presenters

Eric Moore, MD

Dr. Moore is a head and neck cancer surgeon and facial plastic and reconstructive surgeon in the department of Otolaryngology-Head and Neck Surgery. Dr. Moore specializes in complex tumor removal and reconstructive surgery of the Head ...

View full profile

Katharine Price, MD

Head and Neck Cancer Center

View full profile

Daniel Ma

Head and Neck Cancer Center

View full profile

Related Videos

Exploring colorectal cancer clinical trials

Mayo Clinic colorectal cancer experts Jeremy C. Jones, M.D., and Tanios S. Bekaii-Saab, M.D., provide an overview of colorectal cancer clinical trials that are transforming the way this disease is treated.

Robotic bronchoscopy

Robotic bronchoscopy uses flexible robotics that enable new possibilities in endoscopy. Karen L. Swanson, D.O., pulmonologist at Mayo Clinic in Arizona, shares the latest on robotic bronchoscopy and looks ahead to what this means for lung cancer.

How to do 3D modeling for cardiothoracic surgery

Shanda Blackmon, M.D., M.P.H., professor of surgery and thoracic surgeon at Mayo Clinic in Rochester, Minnesota, shares how to use 3D modeling for CT surgery.

Minimally invasive approach to Pancoast tumor using 3D printing

Shanda Blackmon, M.D., M.P.H., professor of surgery and thoracic surgeon at Mayo Clinic in Rochester, Minnesota, shares a case presentation on hybrid Pancoast tumor resection.

Multifocal lung cancer discussion and case presentation

Shanda Blackmon, M.D., M.P.H., professor of surgery and thoracic surgeon at Mayo Clinic in Rochester, Minnesota, shares a case presentation on VATS left lower lobectomy in the setting of multiple lung lesions.

Gastric cancer overview

Travis E. Grotz, M.D. discusses stomach (gastric) cancer risks, signs and symptoms, diagnosis, staging, and treatments including hyperthermic intraperitoneal chemotherapy (HIPEC) and immunotherapy.

Treatment options for advanced kidney cancer

Bradley C. Leibovich, M.D., a urologic surgeon specializing in the treatment of kidney cancer at Mayo Clinic in Rochester, Minnesota, discusses the symptoms that patients with kidney tumors may — or may not — experience, as well as treatment ...

HIPEC surgery for metastatic GI cancer

Sanjay P. Bagaria, M.D., discusses hyperthermic intraperitoneal chemotherapy (HIPEC) surgery for peritoneal carcinomatosis secondary to gastrointestinal (GI) cancers. HIPEC surgery involves removal of all visible cancer in the abdomen ...

Cancer care at Mayo Clinic's campus in Arizona

Mayo Clinic experts in Arizona discuss the new facility, which allows them to create a seamless experience for patients by integrating all cancer services from prevention to survivorship.

Unlocking the power of gene expression: Molecular classification of brain tumors

Mayo Clinic physicians and researchers discuss how the molecular makeup of brain tumors can be used to identify five categories of gliomas, each with different clinical features and outcomes.

Genes of colon cancer recurrence differ among blacks, whites and Asians

The genetic makeup of colon cancer tumors and survival rates for people with the disease differ by race, according to a study from researchers at the Mayo Clinic Cancer Center.

Prior oral contraceptive use associated with better outcomes for patients with ovarian cancer

Patients who develop ovarian cancer appear to have better outcomes if they have a history of oral contraceptive use, according to a study by Mayo Clinic researchers published in the current issue of the journal BMC Cancer.

New model to assess breast cancer risk more accurate than current option

A new breast cancer risk-prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately classified breast cancer risk than the ...

Mayo researchers developing a new way to screen for endometrial cancer

Researchers at Mayo Clinic have shown that it is possible to detect endometrial cancer using tumor DNA picked up by ordinary tampons.

Proton therapy has advantages over IMRT for advanced nasal cavity and paranasal sinus cancer

Robert L. Foote, M.D., comments on findings of a new study by radiation oncologists at Mayo Clinic, comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base.

Minimally invasive inguinal lymph node dissection (MILND)

Jakub James, M.D., demonstrates the operative technique of minimally invasive inguinal lymph node dissection in patients with melanoma. This video is intended for a surgical audience and is not intended to replace hands-on training.

Treatment for people with cholangiocarcinoma at Mayo Clinic

Rory L. Smoot, M.D., describes treatment options and the specialized team of experts at Mayo Clinic who provide care for patients with cholangiocarcinoma.

Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients

Amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC), has shown that the presence of HER2 amplification is associated with particularly aggressive tumors.

Lymphoma patients event-free two years after diagnosis have a normal life expectancy

Newly diagnosed patients with diffuse large B cell lymphoma (DLBCL) who do not experience any cancer-related outcome events for two years after diagnosis have essentially the same life expectancy as they did prior to diagnosis, a Mayo ...

Faster tumor analysis software speeds cancer discoveries

With the glut of data generated through next-generation sequencing, interpretation has become the new bottleneck in scientific discovery and clinical application.

Tissue testing during breast cancer lumpectomies prevents need for re-operation 96 percent of time

Unique laboratory testing during breast cancer lumpectomies to make sure surgeons removed all the cancerous tissue spares patients the need for a repeat operation in roughly 96 percent of cases at Mayo Clinic in Rochester, Minnesota.

The increasing incidence of young-onset colorectal cancer: A call to action

Dr. Whitney Jones from the University of Kentucky in Louisville, and Jasmine Greenamyer from the Colon Cancer Alliance in Washington, D.C., discuss the article appearing in the February 2014 issue of Mayo Clinic Proceedings.

The high cost of cancer drugs and what we can do about it

S. Vincent Rajkumar, M.D., a hematologist from Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the October 2012 issue of Mayo Clinic Proceedings, where he explains the reasons behind the high cost of cancer treatments in the U.S.

Residential and outpatient treatment comparison for tobacco dependence

J. Taylor Hays, M.D., associate professor of medicine at Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the March 2011 issue of Mayo Clinic Proceedings.

Nonclonal serum immunoglobulin free light chains to predict overall survival

S. Vincent Rajkumar, M.D., reviews his Olmsted County population-based study investigating the detection of high polyclonal free light chain levels as a predictor of mortality outcomes across multiple conditions.

Monoclonal gammopathy-associated proliferative glomerulonephritis — S. Vincent Rajkumar, M.D.

S. Vincent Rajkumar, M.D., in the Department of Hematology at Mayo Clinic, introduces and explains the importance of recognizing monoclonal gammopathies as a major cause of proliferative glomerulonephritis.

Monoclonal gammopathy-associated proliferative glomerulonephritis — Sanjeev Sethi, M.D., Ph.D.

Sanjeev Sethi, M.D., Ph.D., a professor of laboratory medicine and pathology at Mayo Clinic, presents findings that define the role of monoclonal proteins in proliferative glomerulonephritis and propose evaluation and new treatment algorithms ...

Melanoma in immunosuppressed patients

Jerry D. Brewer, M.D., M.S., a dermatologic surgeon from the Department of Dermatology at Mayo Clinic in Rochester, Minnesota, unmasks a previously unknown higher risk of melanoma in immunosuppressed and transplant patients.

Grand Rounds: Overview of the Mayo Clinic Cancer Center

Robert B. Diasio, M.D., presents Overview of the Mayo Clinic Cancer Center.

Grand Rounds: Breast Cancer Susceptibility

Fergus J. Couch, Ph.D., presents Breast Cancer Susceptibility.

Increasing incidence of melanoma among middle-aged adults

Jerry D. Brewer, M.D., M.S., discusses his article, which noted increased survival rates for incidences of melanoma, in Olmsted County, Minnesota, demonstrating early-diagnosis effectiveness.

Stem cell transplantation as a treatment for multiple myeloma — Mayo Clinic

Multiple myeloma is a cancer of the plasma cells, which are found in the bone marrow or blood-producing tissue that fills spaces within the bones.

Breakthroughs in the treatments for melanoma

Richard W. Joseph, M.D., medical oncologist at Mayo Clinic's campus in Florida, talks about the most deadly form of skin cancer, known as melanoma.

Cancer and pregnancy: Parallels in growth, invasion and immune modulation

Shernan Holtan, M.D., instructor in medicine and oncology at Mayo Clinic, discusses her November 2009 Mayo Clinic Proceedings article on the parallels between cancer and pregnancy, particularly in terms of immune modulation.

Aromatase inhibitors in breast cancer survivors

Sandhya Pruthi, M.D., director of the Breast Diagnostic Clinic at Mayo Clinic's campus in Rochester, Minnesota, discusses her article on managing aromatase inhibitors in breast cancer survivors.

Diagnosing and managing patients with BRCA mutations

Sandhya Pruthi, M.D., consultant in the Breast Diagnostic Clinic at Mayo Clinic in Rochester, Minnesota, discusses her December 2010 Mayo Clinic Proceedings article on diagnostic and management approaches to patients with BRCA mutations ...

Fertility preservation

Dr. Jani Jensen, assistant professor in the Department of Reproductive Endocrinology and Infertility at Mayo Clinic's campus in Rochester, Minnesota, discusses her article on fertility preservation.

Employment and education are associated with survival in skin melanoma

Dr. Mario Mandala, a medical oncologist and clinical assistant in the Unit of Medical Oncology, from Riuniti Bergamo Hospital in Bergamo, Italy, comments on the results of a study, appearing in Mayo Clinic Proceedings, February 2011 issue.

Abnormal cervical appearance: What to do, when to worry?

Petra M. Casey, M.D., discusses common cervical lesions encountered in practice and distinguishes those that can be safely observed from those needing further evaluation by a gynecologist.

Idiopathic retroperitoneal fibrosis: Clinical presentation, treatment and outcomes

Tanaz Kermani, M.D., assistant professor of medicine at Mayo Clinic, Rochester, Minnesota, provides an overview of findings in a large series of patients with idiopathic retroperitoneal fibrosis.

Malignant fibrous histiocytoma in CLL and Non-Hodgkin lymphoma

Jerry D. Brewer, M.D., M.S., a dermatologic surgeon in the Department of Dermatology at Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the August 2011 issue of Mayo Clinic Proceedings.

Genomic testing and risk perception in patients receiving preventive health care

Dr. Clayton Cowl, associate professor of medicine from the Division of Preventive, Occupational, and Aerospace Medicine at Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the October 2011 issue of Mayo Clinic Proceedings.

Hepatocellular carcinoma in Olmsted County, Minnesota, 1976-2008

W. Ray Kim,M.D., associate professor of medicine and hepatologist at Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the January 2012 issue of Mayo Clinic Proceedings.

Transcriptional profiling by sequencing of oropharyngeal cancer

Dr. Rebecca Laborde, postdoctoral research fellow at Mayo Clinic in Rochester, Minnesota, shares the results of a study appearing in the March 2012 issue of Mayo Clinic Proceedings.

Increasing incidence of melanoma among young adults

Dr. Kurtis Reed, a resident physician in the Department of Dermatology at Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the April 2012 issue of Mayo Clinic Proceedings.

Common musculoskeletal tumors of childhood and adolescence

Carola A S. Arndt, M.D., a pediatric hematologist from Mayo Clinic in Rochester, Minnesota, discusses her article appearing in the May 2012 issue of Mayo Clinic Proceedings.

The high cost of cancer drugs and what we can do about it

Mustaqeem A. Siddiqui, M.D., a specialist in Hematology and Oncology at Mayo Clinic in Rochester, Minnesota, introduces his article appearing in the October 2012 issue of Mayo Clinic Proceedings on the high cost of cancer treatments.

Study shows potential to prevent hospitalizations in brain tumor patients

In a retrospective five-year study, researchers at Mayo Clinic found that common causes of hospitalization for patients with malignant brain tumors, such as seizures, are potentially preventable.

Gene is linked to lung cancer development in never smokers

A five-center collaborative study that scanned the genomes of thousands of "never smokers" diagnosed with lung cancer as well as healthy never smokers has found a gene they say could be responsible for a significant number of those cancers.

View More Videos

Medical Professional Video Center

Search Video Center